Rate this post

Ro.co vs Willow: Compare GLP-1 Programs & Pricing

Side-by-side Ro.coand Willow: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.

Ro.co and Willow are two established telehealth providers offering GLP-1–based weight management programs. This article compares Ro.co vs Willow to help you identify which best fits your goals and preferences.

Visit Ro.co
Explore Willow

Ro.co vs Willow: Quick Overview

Provider	Semaglutide	Tirzepatide	Promo	Membership
Ro.co			Brand med access (Code: )	$145.00 — Yes
Willow	$299.00	$399.00	Best for Oral and Injectable (Code: )	— No

Ro.co vs Willow: Medical Process & Accessibility

Ro.co focuses on a rapid telehealth intake that includes a digital questionnaire, a brief video or phone visit, and clinician approval within 24‑48 hours. Once approved, the prescription is sent to a licensed U.S. pharmacy that compounds the medication and ships it directly to your door.

Start with Ro.co

Willow follows a slightly longer onboarding workflow. After the initial health assessment, a board‑certified obesity specialist reviews your case, sets a starting dose, and schedules regular virtual follow‑ups to titrate the dose safely. Willow also partners with accredited compounding pharmacies and offers both oral and injectable formulations.

Explore Willow

Ro.co vs Willow: Pricing Comparison

Ro.co starts semaglutide at and tirzepatide at , while Willow begins at $299.00 for semaglutide and $399.00 for tirzepatide. Because Willow provides the only disclosed starting prices, those figures are highlighted in bold.

Both companies advertise promotional language. Ro.co lists “Brand med access” (no specific code) and charges a $145.00 membership fee that must be paid to access the program. Willow’s promotion reads “Best for Oral and Injectable,” and there is no membership fee required.

Compare Willow Pricing

Ro.co vs Willow: Clinical Oversight & Support

Clinical oversight is a core compliance requirement for any FDA‑regulated telehealth service. Both Ro.co and Willow employ licensed physicians, nurse practitioners, and pharmacists who review each patient’s medical history, confirm contraindications, and provide ongoing monitoring.

Ro.co’s model is built for speed; once the clinician signs off, you receive a prescription and can begin treatment quickly. Willow, on the other hand, emphasizes continuous dose optimization, offering scheduled check‑ins (typically every 2‑4 weeks) to adjust dosage based on weight loss progress and side‑effect profile.

Book a Consultation with Ro.co

Ro.co vs Willow: Medication Quality & Safety

Both platforms dispense compounded GLP‑1 medications from pharmacies that follow United States Pharmacopeia (USP) standards and are inspected by state boards of pharmacy. While these compounded products are not identical to brand‑name Wegovy® or Mounjaro®, they contain the same active ingredients and are legally prescribed when a licensed clinician determines they are appropriate for the patient.

FDA guidance requires that telehealth providers only prescribe GLP‑1 agonists after a thorough assessment of medical history, current medications, and potential contraindications (e.g., personal or family history of medullary thyroid carcinoma). Both Ro.co and Willow incorporate these safeguards into their intake questionnaires and clinician reviews.

Ro.co vs Willow: Customer Experience

Customer reviews on independent forums highlight distinct strengths. Ro.co is praised for its affordability, streamlined onboarding, and fast shipping times—often delivering medication within 5‑7 business days after approval. Willow receives accolades for its personalized support, frequent clinician touchpoints, and the option to receive oral semaglutide, which some patients find easier to administer.

Both companies provide an online portal where you can track your prescription status, view lab results, and message your care team. The portals are HIPAA‑compliant, ensuring your health information remains private and secure.

Explore Willow Reviews

Ro.co vs Willow: Final Verdict

If you prioritize a lower upfront cost and a fast, self‑service experience, Ro.co may be the better choice, especially if you are comfortable managing dose adjustments with less frequent clinician contact.

If you value ongoing clinical guidance, the option for oral GLP‑1 therapy, and a program that does not require a membership fee, Willow is likely the more suitable platform.

Both providers operate under telehealth regulations, employ licensed clinicians, and adhere to FDA safety standards for compounded medications. Your decision should weigh cost, desired level of medical support, and preferred route of administration.

Join Ro.co
Get Started with Willow

Disclaimer

This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.

⭐ Editor’s Choice